Photo:

Cancer

From solid tumors to metastatic carcinomas and leukemia: cancer is among the most common causes of death and has many faces. Keep reading for latest developments in early detection, staging, therapy and research.

Photo

News • mpMRI vs TURBT

Bladder cancer: MRI scanning and biopsy as shortcut to correct treatment

Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research suggests that initial MRI imaging and biopsy could reduce wait times.

Photo

News • Machine learning prediction

AI opens non-surgical way to detect brain cancer metastasis

Researchers have developed an artificial intelligence (AI) model to detect the spread of metastatic brain cancer using MRI scans, offering insights into patients’ cancer without aggressive surgery.

Photo

News • Promising prototype

A “diagnostic wand” to detect oral cancer

Liverpool physicists have developed a “diagnostic infrared wand” to more accurately predict the prognosis of oral cancer lesions than current H&E staining techniques.

Photo

News • Osteosarcoma research

Driver behind aggressive bone cancer identified

By analysing the largest collection of whole-genome data from osteosarcoma patients, researchers identified a driving mechanism behind the aggressive development of these bone cancer tumours.

Photo

News • Surprising insights

Research explains how tumor cells die after radiotherapy

Why does radiation therapy kill cancer cells from the same tumour in different ways? This has long remained poorly understood. Now, new findings open up opportunities to improve treatment.

Photo

News • Research on MRD in tongue cancer

Understanding chemotherapy resistance in oral cancers using organoids

Tongue cancer cells can become resistant to chemotherapy under certain circumstances. Investigating these mechanisms, researchers shed light on promising avenues toward new treatments for this cancer.

Photo

Sponsored • Collaboration in pathology

MEDIPATH makes a step towards lab automation with the help of Sakura Finetek Europe

Sakura Finetek Europe and MEDIPATH, a group of independent French pathologists, announced their collaboration to enhance cancer diagnostics and thus contribute to improved patient therapeutic management. This decision is part of an ongoing commitment to improving the quality of care provided to patients and in response to the significant increase in cancer cases over the last years.

911 show more articles
Subscribe to Newsletter